Wedge Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-289,023
| Closed | -$1.28M | – | 526 |
|
|
2024
Q4 | $1.28M | Sell |
289,023
-25,820
| -8% | -$114K | 0.02% | 388 |
|
|
2024
Q3 | $1.3M | Buy |
+314,843
| New | +$1.3M | 0.02% | 388 |
|
|
2023
Q3 | – | Sell |
-248,755
| Closed | -$2.65M | – | 506 |
|
|
2023
Q2 | $2.65M | Buy |
248,755
+228,193
| +1,110% | +$2.43M | 0.04% | 340 |
|
|
2023
Q1 | $216K | Buy |
20,562
+5,659
| +38% | +$59.5K | ﹤0.01% | 398 |
|
|
2022
Q4 | $185K | Sell |
14,903
-86
| -0.6% | -$1.07K | ﹤0.01% | 406 |
|
|
2022
Q3 | $155K | Hold |
14,989
| – | – | ﹤0.01% | 390 |
|
|
2022
Q2 | $173K | Buy |
14,989
+15
| +0.1% | +$173 | ﹤0.01% | 395 |
|
|
2022
Q1 | $188K | Sell |
14,974
-3,409
| -19% | -$42.8K | ﹤0.01% | 408 |
|
|
2021
Q4 | $214K | Buy |
18,383
+3,182
| +21% | +$37K | ﹤0.01% | 386 |
|
|
2021
Q3 | $199K | Buy |
15,201
+3,657
| +32% | +$47.9K | ﹤0.01% | 387 |
|
|
2021
Q2 | $149K | Sell |
11,544
-1,793
| -13% | -$23.1K | ﹤0.01% | 388 |
|
|
2021
Q1 | $149K | Sell |
13,337
-4,594
| -26% | -$51.3K | ﹤0.01% | 516 |
|
|
2020
Q4 | $204K | Buy |
+17,931
| New | +$204K | ﹤0.01% | 535 |
|